• Cancel
    Date：2021-02
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=832

    As a leading company in radiopharmaceutical targeted diagnosis and treatment, Sinotau Pharmaceutical announced a Series D financing of RMB 320 million. This follows the RMB 280 million raised in Series C financing in July 2020 from investors such as Ruiyi

  • Cancel
    Date：2021-02
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=519

    Guangzhou Weiyuan (Vision Medicals) Gene Technology Co., Ltd. (hereinafter referred to as “Vision Medicals” or the “Company”), a leader in the infection precision medicine industry, recently announced the completion of a Series B financing round of several hundred million RMB. This round of financing was led by CDH Investment, with participation from CICC Qichen and existing shareholders, Volcanics Venture and Cash Capital. This round of financing will primarily be used for funding product R&D, establishing a clinical testing network, driving product registration efforts, constructing manufacturing facilities, improving clinical services, and increasing brand marketing. CEC Capital Group served as the exclusive financial advisor of Vision Medicals in this transaction.

  • Cancel
    Date：2021-02
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=828

    Nubo Med, a leading provider of Internet of Things (IoT)-based integrated smart hospital software and hardware solutions, announced today the closing of a Series B financing round, raising several hundred of million RMB. The round was led by SAIF Partners

  • Cancel
    Date：2021-01
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=829

    4Paradigm announced the closing of its Series D financing, raising $700 million. The round was led by Boyu Capital, Primavera Capital, and HOPU Investment, and included strategic investors such as the National Manufacturing Transformation Fund, China Deve

  • Cancel
    Date：2021-01

    CEC Capital Served as Financial Advisor

  • Cancel
    Date：2021-01
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=830

    HiveBox Holdings Limited plans to sign a "Share Purchase Agreement" and "Shareholders' Agreement" with Trustbridge Partners VII, L.P., AsiaForge (Cayman) Ltd., SCC Growth VI 2020 F, L.P., Redview Capital Investment VII Limited, All-Stars PEI ISP VI Limite

  • Cancel
    Date：2020-12
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=535

    CEC Capital Group serves as exclusive financial advisor Beijing Haosi (Health) Biotechnology Co., Ltd. (hereinafter referred to as "Haosi Bio" or the "Company"), a leading provider of solutions for clinical mass spectrometry detection, today announced th

  • Cancel
    Date：2020-12

    CEC Capital Served as Financial Advisor

  • Cancel
    Date：2020-12
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=508

    GaiaWorks (the “Company”), a workforce management cloud service provider, announced that it has completed its RMB 500 million Series D1 financing round, led by GGV Capital. Tencent Holdings, EDBI, and Index Capital China also participated in the round. Previous shareholders Matrix Partners China also increased their holdings in the Company.